Steven Burke
Hoofd Techniek/Wetenschap/O&O bij AKEBIA THERAPEUTICS, INC.
Vermogen: 383 981 $ op 31-05-2024
Actieve functies van Steven Burke
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AKEBIA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-06-2019 | - |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD. | Directeur/Bestuurslid | - | - |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | Directeur/Bestuurslid | - | - |
Loopbaan van Steven Burke
Eerdere bekende functies van Steven Burke
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PROTARA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | 01-01-2019 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-1994 | 01-01-2001 |
PROTARA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Glaxo, Inc. | Corporate Officer/Principal | - | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2000 | - |
Algemeen Adviseur | 01-01-2000 | - |
Opleiding van Steven Burke
Weill Cornell Medical College | Doctorate Degree |
Harvard College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Canada | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 5 |
Director/Board Member | 2 |
General Counsel | 1 |
Sectoraal
Health Technology | 8 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AKEBIA THERAPEUTICS, INC. | Health Technology |
PROTARA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Glaxo, Inc. | |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD. | Health Technology |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Steven Burke
- Ervaring